Proteomic analysis of central nervous system inflammation in multiple sclerosis.

多发性硬化症中枢神经系统炎症的蛋白质组学分析。

• 批准号: LP0990788
• 负责人: Prof Shaun McColl
• 金额: $ 26.33万
• 依托单位: The University of Adelaide
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-02-03 至 2012-07-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0990788
• 关键词: Proteomic; analysis; central; nervous; system

This project aims to identify new therapeutic targets and diagnostics for Multiple Sclerosis (MS) the most common neurological disease in young adults. The estimated economic burden of this disease in Australia is around $2 billion per annum. There is also a large social cost to take into account. In spite of a great deal of research, current therapies are limited. We expect that this this research will: lead to new therapies and better diagnostics, which will reduce the financial and human cost of this disease; generate IP with subsequent economic benefits and; expand proteomics technologies which will have flow on effects including economic benefits and benefits to a wide range of basic research.

该项目旨在确定多发性硬化症（MS）的新治疗靶点和诊断方法，多发性硬化症是年轻人中最常见的神经系统疾病。据估计，这种疾病在澳大利亚每年造成的经济负担约为20亿美元。 还需要考虑到巨大的社会成本。 尽管有大量的研究，目前的治疗方法是有限的。我们希望这项研究将：导致新的疗法和更好的诊断，这将减少这种疾病的财务和人力成本;产生具有后续经济效益的知识产权;扩大蛋白质组学技术，这将产生包括经济效益和广泛基础研究效益在内的流动效应。